Consensus-Based Minimum Requirements for the Adoption of a Computational Pathology Algorithm for Tumor Budding in Colorectal Cancer: An Early Health Technology Assessment
JCO Clinical Cancer Informatics · 2026-07 · 10 (3)
DOI: 10.1200/cci-26-00034 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2026-07. Verfasst von Julie E M Swillens und 4 weiteren Autor:innen. Beteiligte Einrichtung: Radboud University Medical Center, IQ Health Science Department, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Algorithms, Technology Assessment, Biomedical. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE Tumor budding (TB) is an independent prognostic biomarker for colorectal cancer (CRC), yet its clinical adoption is limited by labor-intensive and subjective visual scoring. Computational pathology (CPath) algorithms using deep learning offer potential to improve efficiency and reproducibility. Using an international Delphi study, we established consensus requirements to guide validation and clinical adoption of CPath algorithms, aiming to enhance diagnostic accuracy and patient care. METHODS A two-round international Delphi process was conducted, involving international experts, to reach consensus on predefined statements. In round 1, baseline characteristics were collected and participants were asked to rank statements representing the minimal requirements for the implementation of a CPath algorithm for TB assessment. After completion of this round, participants received a personalized feedback report summarizing interim results for items that lacked consensus. In round 2, participants re-evaluated their initial responses to statements without consensus, in the light of anonymized group feedback provided in their personalized report. RESULTS Fifty-nine pathologists participated in round 1, with a 90% response rate in round 2. Consensus was reached for 21 of 29 (72%) minimal requirements. All reached consensus by agreement. Eight statements (28%) remained without consensus after round 2. CONCLUSION Agreement was reached on the technical, organizational, ethical, and legal aspects, although some requirements were not agreed upon. This highlights the importance of evaluations that take specific contexts into account, as well as the need for continuous stakeholder engagement throughout the development and implementation phases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Radboud University Medical Center, IQ Health Science Department, Nijmegen, the Netherlands.
- Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.
- Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.
- Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden.
ORCID-Profile: Julie E M Swillens, Iris D Nagtegaal, Jeroen A W M Van der Laak
Zitieren
APA
Swillens, J. E. M., Nagtegaal, I. D., Lugli, A., Van der Laak, J. A. W. M., & Tummers, M. (2026). Consensus-Based Minimum Requirements for the Adoption of a Computational Pathology Algorithm for Tumor Budding in Colorectal Cancer: An Early Health Technology Assessment. JCO Clinical Cancer Informatics, 10(3). https://doi.org/10.1200/cci-26-00034
Vancouver
Swillens JEM, Nagtegaal ID, Lugli A, Van der Laak JAWM, Tummers M. Consensus-Based Minimum Requirements for the Adoption of a Computational Pathology Algorithm for Tumor Budding in Colorectal Cancer: An Early Health Technology Assessment. JCO Clinical Cancer Informatics. 2026;10(3). doi:10.1200/cci-26-00034
BibTeX
@article{Swillens2026,
author = {Swillens, Julie E M and Nagtegaal, Iris D and Lugli, Alessandro and Van der Laak, Jeroen A W M and Tummers, Marcia},
title = {Consensus-Based Minimum Requirements for the Adoption of a Computational Pathology Algorithm for Tumor Budding in Colorectal Cancer: An Early Health Technology Assessment},
journal = {JCO Clinical Cancer Informatics},
year = {2026},
volume = {10},
number = {3},
doi = {10.1200/cci-26-00034}
}
EUVIMED